Clinical Overview

Bunny lines (wrinkles on the lateral nasal bridge and nasal ala) are subtle but distinctive wrinkles that appear during smiling or scrunching the nose. These dynamic lines result from contraction of the nasalis muscle, which has medial and alar portions. Botox (onabotulinumtoxinA) in small doses (4-8 units) addresses bunny lines as an adjunctive treatment to broader facial rejuvenation, particularly in patients seeking comprehensive improvement or those developing these lines after Botox treatment for glabellar lines (reduced frowning causes greater nose scrunching).

Anatomical Considerations and Muscle Physiology

The nasalis muscle consists of three functional portions: pars transversa (compresses nasal bridge, creates visible lines), pars alaris (flares nostrils), and levator labii superioris alaeque nasi (elevates lip/nostril). Innervated by buccal and zygomatic branches of the facial nerve (CN VII), the nasalis is relatively small compared to corrugator or orbicularis oculi muscles. Bunny lines appear as 2-4 horizontal lines on the lateral nasal bridge/ala, particularly prominent during smiling, nostril flaring, or facial expressions of disgust. These lines are cosmetically bothersome primarily to patients with specific aesthetic concerns or those developing secondary lines after other Botox treatments.

Mechanism of Action

Botox blocks acetylcholine at the nasalis neuromuscular junction through SNAP-25 protein cleavage, preventing muscle contraction. With dosing of 4-8 units total (2-4 units per side), the nasalis becomes partially paralyzed, reducing line formation and softening pre-existing wrinkles. Effects are temporary, lasting 12-16 weeks. Onset occurs at 3-7 days with peak effect at 10-14 days. Unlike larger muscles (corrugator, orbicularis oculi), the small nasalis demonstrates rapid onset due to smaller muscle mass.

Treatment Protocol and Injection Technique

Dosing: 4-8 units total Botox (2-4 units per side), injected into the nasalis pars transversa on the lateral nasal bridge at the level of the nasal ala. Injection points placed approximately 0.5-1 cm lateral to the nasal bridge midline, 1-2 cm above the alar base. Using 30-gauge needle with 0.05-0.1 mL per side, injections target the muscle bulk responsible for line formation. Conservative dosing essential—excessive doses risk reducing nasal flare ability (desired for some aesthetic procedures but undesirable if unintended). Treatment takes 2-3 minutes as adjunctive procedure. Often combined with larger treatments (glabellar, forehead, crow's feet) in single session.

Results Timeline and Patient Experience

Softening of bunny lines appears at 3-5 days; peak improvement at 10-14 days. Dynamic lines during smiling improve most dramatically; static lines at rest improve gradually. Partial persistence of lines at rest is common, particularly for deeper pre-existing wrinkles. Most patients report 60-80% improvement in line prominence during facial expression. Results last 12-16 weeks, requiring re-treatment for maintenance. Many patients combine bunny line treatment with glabellar, forehead, and crow's feet Botox in quarterly sessions rather than treating bunny lines separately.

Ideal Candidates and Patient Selection

Ideal candidates: patients with visible bunny lines during smiling or facial expression, concern about these specific lines (cosmetically bothersome to individual), and realistic expectations about partial improvement. Bunny lines less responsive to Botox than larger muscle groups due to anatomical limitations. Poor candidates: patients with minimal baseline bunny lines (Botox unnecessary), those unable to accept subtle results, or patients with previous adverse reactions to neurotoxins. Often treated as adjunctive procedure rather than standalone indication.

Comparison with Stand-Alone vs. Combination Approach

Stand-alone bunny line treatment (rare): 4-8 units Botox for isolated bunny lines in patient with no other facial lines. Combination approach (common): bunny line treatment incorporated into comprehensive facial rejuvenation alongside glabellar (20 units), forehead (15 units), and crow's feet (24 units total) in single session. Combination approach is more efficient, provides better aesthetic outcome, and justifies consultation visit cost-effectively compared to treating bunny lines separately.

Risks and Complications

Adverse events at 4-8 unit doses are minimal: temporary bruising (5-10%), mild swelling (1-5%), redness at injection sites (24-48 hours). Serious adverse events virtually non-existent at these small doses. Potential complication: nasal flare reduction if injections placed too deep or doses excessive (>8 units per side), limiting ability to flare nostrils—rarely problematic cosmetically but occasionally noticed by patients. Asymmetry (15-20%) may occur if bilateral dosing unequal, often improved at 2-week touch-up visit. No neurotoxin reversal exists; complications resolve naturally over 12-16 weeks.

Combination with Fillers and Alternative Treatments

Botox addresses only dynamic bunny lines. Static wrinkles present at rest benefit from hyaluronic acid fillers (Juvéderm, Restylane) injected along the nasal bridge. Combining 4-8 units Botox (paralyzes nasalis muscle) with 0.3-0.5 mL filler along nasal bridge provides optimal results for both dynamic and static components. Alternative treatment: chemical peel (15-25% TCA) or laser resurfacing improves skin texture and fine wrinkles. Radiofrequency microneedling stimulates collagen for skin tightening. For severe bunny lines, combination approach (Botox + filler + laser) produces superior outcome compared to monotherapy.

When to Consult a Specialist

Board-certified dermatologists should perform bunny line treatment as part of comprehensive facial evaluation and treatment. If treating bunny lines in isolation (uncommon), specialist assessment determines whether isolated treatment addresses patient concerns or whether additional facial areas require attention. Complications (asymmetry, nasal flare loss, unexpected outcomes) warrant specialist follow-up; most resolve naturally within 12-16 weeks.

FAQ

Q: Will Botox prevent me from flaring my nostrils?
A: At conservative doses (4-8 units), no. The nasalis pars alaris (responsible for nostril flare) remains partially functional. Only with excessive overdosing (>10 units per side) does flaring become noticeably impaired—rare complication with experienced injectors.

Q: Are bunny lines common enough to treat separately?
A: Not usually. Most patients treat bunny lines as adjunctive component during comprehensive facial Botox (combining glabellar, forehead, crow's feet, and bunny lines in single session). Standalone bunny line treatment is uncommon and rarely cost-effective unless patient has truly isolated concern.

Q: How much does bunny line Botox cost?
A: Typically $60-120 (4-8 units at $10-15/unit) if treated separately. However, many clinics add bunny line treatment to comprehensive facial Botox as add-on without additional charge, or minimal charge ($20-40) since same appointment is already scheduled.

Q: Will treating my glabellar lines make my bunny lines worse?
A: Potentially. Paralyzing corrugator/procerus muscles (frowning muscles) may shift movement to nasalis muscle (scrunching), making bunny lines more prominent in some patients. This is reversible; many patients subsequently add bunny line Botox to existing regimen to address this secondary effect.

Conclusion

Botox for bunny lines uses conservative doses (4-8 units) to address dynamic wrinkles on lateral nasal bridge from nasalis muscle contraction. Results appear at 3-7 days, peak at 10-14 days, lasting 12-16 weeks. Efficacy approaches 60-80% improvement in line prominence during expression; deeper static lines may benefit from combined filler treatment. Adverse events minimal at low doses; serious complications essentially non-existent. Bunny line treatment rarely stands alone—most commonly incorporated into comprehensive facial Botox combining multiple areas in single session. Board-certified dermatologists should perform injections to ensure proper nasalis targeting and aesthetic outcome. Combination with fillers or laser resurfacing optimizes results for patients with significant static bunny line component.

References

  1. Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol. 1992;18(1):17-21.
  2. Flynn TC, Carruthers A, Carruthers JD. Advancements in botulinum toxin. Dermatol Clin. 2016;34(2):129-134.
  3. Sclafani AP, Azizzadeh B, McCormick SA. Botulinum toxin: mechanisms of action and clinical applications in cosmetic surgery. Plast Reconstr Surg. 2002;109(2):860-873.
  4. Alam M, Gladstone H, Kramer E, et al. ASDS guidelines of care: injectable fillers. Dermatol Surg. 2008;34(S1):S115-S148.
  5. Carruthers A, Carruthers J. Botulinum toxin in facial rejuvenation: an update. Dermatol Clin. 2013;31(3):519-529.
  6. Matarasso SL, Matarasso A, Brommer S, et al. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg. 2006;118(3S):35S-48S.
  7. Blitzer A, Brin MF, Keen MS, Aviv JE. Botulinum toxin for treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg. 1997;123(4):389-392.
  8. Carruthers A, Carruthers J. Treatments for facial aging with botulinum toxin. Clin Interv Aging. 2007;2(3):401-412.
  9. Beasley KL, Weiss RA, Weiss MA. Hyaluronic acid dermal fillers: a comprehensive review. Am J Clin Dermatol. 2009;10(5):313-318.
  10. Dover JS, Kilmer SL, Anderson RR, et al. Consensus recommendations for combined laser and intense pulsed light therapies. J Am Acad Dermatol. 2003;49(1):28-33.